We Help Companies Find New Sales Opportunities
Aortech is to sell its commercial heart valve business to Kohler Chemie of Germany for £2.7m.
Aortech is looking to sell its commercial operations in order to focus on the development of a new polymer heart valve, and a significant number of the 130 jobs are expected to be lost.
Aortech is to acquire the critical care operations of Becton Dickinson of the US, which manufactures monitoring devices and catheters and includes a factory in Singapore, for £36m.
Aortech is planning to raise £64m in a share issue in order to fund acquisitions and the development of new healthcare devices.
Aortech International is to raise £17m in a share placing, in order to fund the development of its cardiovascular devices.
Aortech is to acquire the Yorkshire-based heart valve business of Tissuemed for up to £1m.